AML patient CD4+ and CD8+ T cells show normal immunophenotypes and can be activated to produce cytokines and proliferate under optimal anti-CD3 and anti-CD28 stimulatory conditions in vitro (206, 207). This evidence concerns the gene CD4 and acute myeloid leukemia.